Bone morphogenetic protein 7 expression associates with bone metastasis in breast carcinomas

Area of Science:

• Oncology
• Molecular Biology
• Cancer Research

Background:

• Bone morphogenetic protein 7 (BMP7) is overexpressed in primary breast tumors.
• Previous research indicated BMP7 overexpression in breast cancer.
• This study investigates the clinical significance of BMP7 expression in breast cancer patients.

Purpose of the Study:

• To explore the clinical significance of BMP7 expression in breast cancer.
• To determine the association between BMP7 expression and breast cancer subtypes and outcomes.
• To evaluate BMP7 as a potential prognostic indicator for bone metastasis.

Main Methods:

• Included 483 breast cancer patients with comprehensive clinicopathological data and long-term follow-up (up to 15 years).
• Analyzed 241 lobular carcinomas, 242 ductal carcinomas, and 40 local recurrences.
• Quantified BMP7 protein expression using immunohistochemistry.

Main Results:

• BMP7 was detected in 47% of primary tumors and 13% of local recurrences.
• BMP7 expression was significantly higher in lobular carcinomas (57%) compared to ductal carcinomas (37%).
• BMP7 expression correlated with accelerated bone metastasis, especially in ductal carcinomas, and was an independent prognostic indicator for early bone metastasis development.

Conclusions:

• BMP7 expression is strongly associated with bone metastasis formation in breast cancer.
• BMP7 may serve as a valuable biomarker for identifying patients at higher risk of bone metastasis.
• This study establishes the first link between the bone-inducing factor BMP7 and the bone metastasis process in breast cancer.